New Key Statistics Module, Z-Score and F-Score
NAS:SXTC Key Ratios
Market Cap $ M | 2.00 |
Enterprise Value $ M | -7.16 |
P/E(ttm) | -- |
PE Ratio without NRI | -- |
Forward PE Ratio | -- |
Price/Book | 0.09 |
Price/Sales | 0.23 |
Price/Free Cash Flow | -- |
Price/Owner Earnings | -- |
Payout Ratio % | -- |
Revenue (TTM) $ M | 1.00 |
EPS (TTM) $ | -16.37 |
Beneish M-Score | -2.78 |
10-y EBITDA Growth Rate % | -- |
5-y EBITDA Growth Rate % | -- |
y-y EBITDA Growth Rate % | -- |
EV-to-EBIT | 2.82 |
EV-to-EBITDA | 3.06 |
PEG | -- |
Shares Outstanding M | 3.48 |
Net Margin (%) | -160.60 |
Operating Margin % | -130.38 |
Pre-tax Margin (%) | -160.60 |
Quick Ratio | 1.51 |
Current Ratio | 1.60 |
ROA % (ttm) | -13.82 |
ROE % (ttm) | -27.58 |
ROIC % (ttm) | -23.77 |
Dividend Yield % | -- |
Altman Z-Score | -1.35 |
SXTC Number of Guru Trades
SXTC Volume of Guru Trades
Gurus Latest Trades with NAS:SXTC
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NAS:SXTC is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
China SXT Pharmaceuticals Inc Insider Transactions
No Available Data
News about NAS:SXTC
Total 0- 1